Justin Michael Francis pleaded not guilty Wednesday to two counts of third-degree rape for incidents in December 2024 and May ...

During a press conference today, the Utah Department of Commerce’s Division of Professional Licensing (DOPL) and law enforcement partners discussed measures to target human trafficking in ...

TOKYO & BASKING RIDGE, N.J., December 22, 2025--(BUSINESS WIRE)--The first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) with or ...

Cancer has evolved to protect itself from our inherent immune responses, and some types of cancer cells have developed their own strategies to evade or withstand treatment. These pro-cancer shields ...

Katrina Carter, DPT, FNS, is a licensed travel physical therapist. She specializes in orthopedics and has a passion for providing education on nutrition for healing and overall health and wellness.

Findings showed in the rinatabart sesutecan 100mg/m 2 cohort, the confirmed ORR was 50%, with 2 patients achieving complete response. The Food and Drug Administration (FDA) has granted Breakthrough ...

Breakthrough Therapy Designation granted to Rina-S for the treatment of adult patients with recurrent or progressive endometrial cancer (EC) who have disease progression on or following prior ...

Genmab has received breakthrough therapy designation from the U.S. Food and Drug Administration for its endometrial cancer treatment. The biotechnology company said Tuesday the decision was supported ...